Why Your Immune System Feels Different After 40, and What NAD+ Has To Do With It

A cold that used to clear quickly now hangs on. Stress seems to hit harder. Recovery from travel, poor sleep, or a demanding month can feel slower than it did ten years ago.

A lot of people write that off as "just getting older." That is not entirely wrong, but the biology is more specific than that. One part of the story appears to involve NAD+, a molecule tied to energy metabolism, inflammatory control, and cellular repair.

What NAD+ Actually Does

NAD+ is a coenzyme found in every living cell. It helps convert food into ATP, supports DNA repair, and fuels proteins such as sirtuins that help regulate stress responses and inflammation [1].

NAD+ levels decline with age, and that decline becomes more meaningful in midlife [1]. This does not affect only one organ system. It affects the operating conditions of many kinds of cells, including immune cells.

The Immune System's Energy Demand

Immune cells are metabolically expensive. T cells, macrophages, and natural killer cells all need energy to activate, proliferate, communicate, and clear threats.

That work depends on functional mitochondria, and mitochondrial function depends heavily on NAD+.

When NAD+ is abundant, immune cells are generally better equipped to coordinate a rapid response. When it is low, response quality may degrade, recovery may slow, and inflammatory regulation may become less precise. This broader age-related shift is part of what researchers describe as immunosenescence [2].

Immunosenescence is not just about getting sick more often. It is also associated with slower healing, weaker vaccine responses, and higher background inflammation.

The Inflammaging Loop

Aging is often accompanied by low-grade chronic inflammation, sometimes called inflammaging [2]. NAD+ decline and inflammaging appear to reinforce each other.

One reason is CD38, an enzyme involved in immune signaling that also consumes NAD+. Research published in Cell Metabolism showed that CD38 activity rises with age and contributes substantially to age-related NAD+ decline [3].

That creates an unfortunate cycle:

• inflammation increases CD38 activity
• CD38 consumes more NAD+
• lower NAD+ weakens cellular regulation
• dysregulated cells contribute to more inflammation

This feedback loop is one reason NAD+ restoration has attracted interest as part of healthy aging research.

What Happens When NAD+ Levels Rise?

The clinical picture is still developing, but early human data is worth noting.

A randomized, multicenter, double-blind, placebo-controlled trial in healthy middle-aged adults found that NMN supplementation significantly increased NAD+ levels over 60 days [4]. The study also reported changes in measures such as walking performance and biological-age-related markers.

That is not the same as proving direct immune improvement. But it supports the idea that NAD+ biology can be shifted in humans in ways that may matter for resilience.

More broadly, restoring NAD+ is thought to influence immune function through several plausible mechanisms:

• supporting sirtuin activity
• improving mitochondrial efficiency in immune cells
• helping regulate inflammatory signaling
• potentially reducing some of the drivers of the CD38 depletion cycle

These mechanisms are biologically coherent, even if large immune-specific injectable NAD+ trials are still limited.

Sirtuins and Immune Aging

Sirtuins help connect NAD+ to immune aging in a more direct way.

SIRT1 helps regulate inflammatory signaling and can suppress NF-kB-related pathways when conditions are favorable [1].

SIRT3 works inside mitochondria and helps maintain cleaner energy production, which matters because dysfunctional mitochondria generate oxidative stress that can further burden immune cells [3].

When NAD+ falls, these systems may work less efficiently. That does not create a single dramatic symptom, but it can contribute to a body that feels slower to recover and less adaptable under stress.

Oral Precursors vs Injectable NAD+

Most published human studies have focused on oral precursors such as NMN and NR, not injectable NAD+ itself.

Injectable NAD+ offers a more direct delivery route. It bypasses gut absorption and precursor conversion, which may make exposure more predictable. That is one reason people interested in physician-supervised longevity protocols often prefer injections.

At the same time, it is important to stay honest: we do not yet have large randomized trials showing that injectable NAD+ directly improves immune outcomes in otherwise healthy adults. The rationale is strong, but the evidence base is still catching up.

Signs Immune Resilience May Be Changing

Not everyone notices immune aging in obvious ways. Sometimes it shows up as:

• slower recovery from routine illnesses
• getting run down more easily after stress or travel
• more lingering fatigue after poor sleep
• wounds or minor infections taking longer to settle
• a general sense that your system is less forgiving than it used to be

None of those symptoms automatically point to NAD+, and none are specific enough to diagnose anything on their own. But they fit the broader pattern of a body working with a little less cellular reserve.

Building Immune Resilience as a Practice

Immune resilience does not come from a single intervention. It is built from sleep, exercise, nutrition, stress regulation, and, increasingly, targeted support for the biology underneath those habits.

NAD+ fits into that picture not as a cure-all, but as a meaningful input into mitochondrial function, inflammatory balance, and recovery capacity.

For people in their 40s and 50s who feel like their system is not bouncing back the way it used to, that makes NAD+ biology worth understanding.

The Bottom Line

Your immune system after 40 is not shaped only by time. It is shaped by cellular resources, and NAD+ appears to be one of them.

The link between NAD+ decline, inflammaging, CD38 activity, and age-related immune change is well established at the mechanistic level. Human intervention studies are growing, but there is still plenty to learn, especially around injectable NAD+ and immune-specific outcomes.

That said, the overall direction of the science is clear enough to make this a serious conversation for people thinking proactively about healthy aging.

Ready to explore how NAD+ therapy might support your resilience and overall vitality? Start with a free physician assessment at RenuviaRX.

---

References

1. Covarrubias AJ, Perrone R, Grozio A, Verdin E. NAD+ metabolism and its roles in cellular processes during ageing. Nature Reviews Molecular Cell Biology. 2021;22:119-141. https://doi.org/10.1038/s41580-020-00313-x

2. Tizazu AM, Mengist HM, Demeke G. Aging, inflammaging and immunosenescence as risk factors of severe COVID-19. Immunity & Ageing. 2022;19:53. https://doi.org/10.1186/s12979-022-00309-5

3. Camacho-Pereira J, Tarragó MG, Chini CCS, et al. CD38 Dictates Age-Related NAD Decline and Mitochondrial Dysfunction through an SIRT3-Dependent Mechanism. Cell Metabolism. 2016;23(6):1127-1139. https://doi.org/10.1016/j.cmet.2016.05.006

4. Yi L, Maier AB, Tao R, Lin Z, Vaidya A, Pendse S, et al. The efficacy and safety of β-nicotinamide mononucleotide supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial. GeroScience. 2023;45:29-43. https://doi.org/10.1007/s11357-022-00705-1

---

These statements have not been evaluated by the FDA. This content is for informational purposes only and does not constitute medical advice.